Neo Kumfurt Pawsef is a powerful broad-spectrum injectable antibiotic formulated with Ceftriaxone Sodium and Sulbactam, designed for the treatment of serious bacterial infections in dogs and cats. This advanced combination provides enhanced antibacterial activity against a wide range of Gram-positive and Gram-negative pathogens, making it an effective choice for veterinary infection management.
Ceftriaxone is a third-generation cephalosporin antibiotic that exerts potent bactericidal activity by inhibiting bacterial cell wall synthesis. Sulbactam acts as a beta-lactamase inhibitor, protecting Ceftriaxone from bacterial enzymes that may otherwise reduce antibiotic effectiveness. Together, they provide synergistic antibacterial action against susceptible organisms, including resistant strains that produce beta-lactamase enzymes.
Pawsef is indicated for dermatological infections, urinary tract infections, respiratory tract infections, bone and joint infections, pneumonia, pyrexia associated with bacterial infections, and perioperative antimicrobial support during surgical interventions. The formulation demonstrates excellent tissue penetration and high bioavailability, allowing effective distribution into various body systems.
Due to its broad-spectrum activity and injectable route of administration, Pawsef is commonly used in moderate to severe infections requiring rapid and reliable antibacterial therapy under veterinary supervision.
KEY BENEFITS
- Broad-spectrum injectable antibiotic therapy
- Combines Ceftriaxone and Sulbactam for enhanced efficacy
- Effective against Gram-positive and Gram-negative bacteria
- Helps manage dermatological infections
- Supports treatment of urinary tract infections
- Effective in respiratory tract infections and pneumonia
- Useful for bone and joint infections
- Provides perioperative antimicrobial support
- High tissue penetration and bioavailability
- Helps combat beta-lactamase-producing bacteria
- Rapid systemic antibacterial action
- Suitable for dogs and cats
COMPOSITION
Pawsef 375 mg
| Ingredient |
Quantity |
| Ceftriaxone Sodium |
250 mg |
| Sulbactam |
125 mg |
Pawsef 750 mg
| Ingredient |
Quantity |
| Ceftriaxone Sodium |
500 mg |
| Sulbactam |
250 mg |
HOW THE ACTIVE INGREDIENTS WORK
Ceftriaxone Sodium
A third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, resulting in bacterial cell death and effective elimination of susceptible pathogens.
Sulbactam
A beta-lactamase inhibitor that protects Ceftriaxone from bacterial resistance mechanisms, thereby expanding antibacterial coverage and improving treatment efficacy.
EFFECTIVE AGAINST SUSCEPTIBLE ORGANISMS
Pawsef demonstrates activity against a wide range of bacteria, including:
- Staphylococci
- Streptococci
- Escherichia coli
- Klebsiella species
- Pseudomonas aeruginosa
- Various Gram-positive organisms
- Various Gram-negative organisms
INDICATIONS / USES
Pawsef is recommended for:
- Dermatological Infections
- Skin and Soft Tissue Infections
- Urinary Tract Infections (UTIs)
- Respiratory Tract Infections
- Pneumonia
- Bone Infections
- Joint Infections
- Pyrexia Associated with Bacterial Infections
- Surgical Interventions
- Moderate to Severe Systemic Bacterial Infections
DOSAGE & ADMINISTRATION
Species
Dogs & Cats
Method of Administration
Intramuscular (IM) or Intravenous (IV) Injection
Administer only under veterinary supervision.
Recommended Dosage
Dogs
15–50 mg/kg body weight
Every 12 to 24 hours by IM or IV route.
Cats
25–50 mg/kg body weight
Every 12 hours by IM or IV route.
Treatment duration should be determined by the veterinarian based on the infection type and clinical response.
AVAILABLE SIZES
| Presentation |
MRP |
| Pawsef 375 mg |
₹85 |
| Pawsef 750 mg |
₹113 |
PRODUCT INFORMATION
|
|
| Brand |
Neo Kumfurt |
| Product Name |
Pawsef |
| Product Type |
Injectable Broad-Spectrum Antibiotic |
| Suitable For |
Dogs & Cats |
| Use For |
Dermatological, Urinary, Respiratory, Bone & Joint Infections |
| Form |
Injection |
| Class |
Third-Generation Cephalosporin Antibiotic with Beta-Lactamase Inhibitor |